Published in J Pediatr on February 01, 1979
Toxigenic clostridia. Clin Microbiol Rev (1990) 5.40
Honey--a remedy rediscovered. J R Soc Med (1989) 3.35
Clostridium botulinum neurotoxin. Microbiol Rev (1980) 2.89
Intestinal toxemia botulism in Italy, 1984-2005. Eur J Clin Microbiol Infect Dis (2007) 1.06
Honey--a novel antidiabetic agent. Int J Biol Sci (2012) 1.01
Infant botulism in Canada. Can Med Assoc J (1981) 0.98
Some preliminary studies on low incidence of infant botulism in the United Kingdom. J Clin Pathol (1987) 0.96
Update: infant botulism. Clin Microbiol Rev (1996) 0.96
Botulinum toxin: bioweapon & magic drug. Indian J Med Res (2010) 0.86
Infant botulism in the United States: an epidemiologic study of cases occurring outside of California. Am J Public Health (1983) 0.86
Equine botulinum antitoxin for the treatment of infant botulism. Clin Vaccine Immunol (2011) 0.84
Medicated Manuka honey in conservative management of exomphalos major. Pediatr Surg Int (2014) 0.83
Antibiotic, pesticide, and microbial contaminants of honey: human health hazards. ScientificWorldJournal (2012) 0.81
Lyophilized airborne Clostridium botulinum spores as inocula that intestinally colonize antimicrobially pretreated adult mice. Infect Immun (1986) 0.79
Genomic Epidemiology of Clostridium botulinum Isolates from Temporally Related Cases of Infant Botulism in New South Wales, Australia. J Clin Microbiol (2015) 0.78
Honey, infant botulism and the sudden infant death syndrome. West J Med (1980) 0.77
High sensitivity detection of active botulinum neurotoxin by glyco-quantitative polymerase chain-reaction. Anal Chem (2014) 0.76
Characterizing the fecal microbiota of infants with botulism. Microbiome (2015) 0.75
Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med (1996) 6.92
Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol (1969) 4.93
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol (1989) 4.30
Infant botulism. Identification of Clostridium botulinum and its toxins in faeces. Lancet (1976) 4.07
Infant botulism. Epidemiological, clinical, and laboratory aspects. JAMA (1977) 3.05
AIDS: an international perspective. Science (1988) 2.84
Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci U S A (1989) 2.73
Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci U S A (1995) 2.70
Inhibition of human telomerase by a G-quadruplex-interactive compound. J Med Chem (1997) 2.66
Intestinal infection and toxin production by Clostridium botulinum as one cause of sudden infant death syndrome. Lancet (1978) 2.60
Risk factors for SIDS. Results of the National Institute of Child Health and Human Development SIDS Cooperative Epidemiological Study. Ann N Y Acad Sci (1988) 2.55
The epidemiology of infertility in Aberdeen. BMJ (1990) 2.44
Prevention of chronic hepatitis B virus infection from mothers to infants in the United States. Pediatrics (1983) 2.41
Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS. J Infect Dis (1989) 2.38
Global surveillance and forecasting of AIDS. Bull World Health Organ (1989) 2.17
OPTN/SRTR 2013 Annual Data Report: kidney. Am J Transplant (2015) 2.11
The international epidemiology of AIDS. Sci Am (1988) 2.08
Secondary neoplasms of the breast: a survey of the 20th Century. Cancer (2001) 2.07
Reciprocal control of RNA-binding and aconitase activity in the regulation of the iron-responsive element binding protein: role of the iron-sulfur cluster. Proc Natl Acad Sci U S A (1992) 2.06
High-intensity focused ultrasound for prostate cancer: a systematic review. Clin Oncol (R Coll Radiol) (2010) 2.02
OPTN/SRTR 2012 Annual Data Report: kidney. Am J Transplant (2014) 2.01
Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. JAMA (1996) 1.99
Cervical cancer screening among Cambodian-American women. Cancer Epidemiol Biomarkers Prev (1999) 1.95
Prevalence of isolated sleep paralysis in black subjects. J Natl Med Assoc (1984) 1.94
A prospective study of household smoking bans and subsequent cessation related behaviour: the role of stage of change. Tob Control (2004) 1.93
Fluorescent treponemal-antibody absorption tests. Studies of false-positive reactions to tests for syphilis. N Engl J Med (1967) 1.91
Filter paper disc method of collecting whole blood for serologic studies in children. Am J Epidemiol (1966) 1.82
Molecular characterization of a second iron-responsive element binding protein, iron regulatory protein 2. Structure, function, and post-translational regulation. J Biol Chem (1994) 1.79
Infant botulism. Annu Rev Med (1980) 1.76
Work site-based cancer prevention: primary results from the Working Well Trial. Am J Public Health (1996) 1.74
MR imaging of head trauma: review of the distribution and radiopathologic features of traumatic lesions. AJR Am J Roentgenol (1988) 1.67
Interleukin 1 beta is localized in the cytoplasmic ground substance but is largely absent from the Golgi apparatus and plasma membranes of stimulated human monocytes. J Exp Med (1988) 1.66
CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells. J Virol (2001) 1.66
Preterm delivery: a public health perspective. Paediatr Perinat Epidemiol (2001) 1.65
Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial. Proc Natl Acad Sci U S A (2001) 1.63
An investigation of the age at menopause. J Biosoc Sci (1972) 1.63
Infertility--epidemiology and referral practice. Hum Reprod (1991) 1.61
Country-specific estimates and models of HIV and AIDS: methods and limitations. AIDS (1999) 1.61
Menopausal age and symptomatology in a general practice. J Biosoc Sci (1973) 1.59
Immunocytochemical detection of interleukin 1 within stimulated human monocytes. J Exp Med (1986) 1.57
Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol (2000) 1.54
Diagnostic screening of mitochondrial DNA mutations in Australian adults 1990-2001. Intern Med J (2004) 1.53
A Method for Obtaining Massive Growth of Bacteria in Fluid Media. Science (1948) 1.53
Botulism--diagnosis, management and public health considerations. Calif Med (1973) 1.52
Role of interleukin 1 in the activation of T lymphocytes. Proc Natl Acad Sci U S A (1988) 1.52
Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. J Immunol (1999) 1.51
Public health implications of rubella antibody levels in California. Am J Public Health (1982) 1.51
Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol (1997) 1.49
The interleukin-1 beta-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy. J Exp Med (1995) 1.47
Follow-up of 186 sterilised women. Lancet (1968) 1.47
Seattle 5 a Day worksite program to increase fruit and vegetable consumption. Prev Med (2001) 1.47
The health of young children in a West African (Gambian) village. Trans R Soc Trop Med Hyg (1970) 1.46
Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial) Am J Cardiol (1996) 1.46
Clinical trial of botulism immune globulin for infant botulism. West J Med (1991) 1.45
Circulating immune complexes in patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol (1979) 1.44
Randomized study of epinephrine versus methoxamine in prehospital ventricular fibrillation. Ann Emerg Med (1989) 1.43
Modified-peptide inhibitors of amyloid beta-peptide polymerization. Biochemistry (1999) 1.40
Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy. J Urol (2003) 1.40
The growth of young children in a Gambian village. Trans R Soc Trop Med Hyg (1968) 1.39
Antipsychotic polypharmacy: a survey of discharge prescriptions from a tertiary care psychiatric institution. Can J Psychiatry (2001) 1.38
"Pap" testing and hysterectomy prevalence: a survey of communities with high and low cervical cancer rates. Am J Epidemiol (1977) 1.38
Family growth in Aberdeen. J Biosoc Sci (1969) 1.38
Infant botulism: epidemiology and relation to sudden infant death syndrome. Epidemiol Rev (1981) 1.38
Local alcohol injection in the treatment of vulvar pruritus. Obstet Gynecol (1972) 1.38
An overview of infant mortality and birth defects in the United States. Teratology (1997) 1.38
A Darkfield Colony Illuminator. Am J Public Health Nations Health (1947) 1.37
Quantitative evidence of intestinal colonization by Clostridium botulinum in four cases of infant botulism. J Infect Dis (1980) 1.37
Evaluation of the qualitative and automated quantitative microhemagglutination assay for antibodies to Treponema pallidum. Appl Microbiol (1972) 1.37
Journal clubs. Br Dent J (2005) 1.36
Outpatient sterilization by laparoscopy. A report of 666 patients. Obstet Gynecol (1971) 1.34
The effects of the dual 5alpha-reductase inhibitor dutasteride on localized prostate cancer--results from a 4-month pre-radical prostatectomy study. Prostate (2006) 1.33
chy1, an Arabidopsis mutant with impaired beta-oxidation, is defective in a peroxisomal beta-hydroxyisobutyryl-CoA hydrolase. J Biol Chem (2001) 1.33
A new binocular approach to the treatment of amblyopia in adults well beyond the critical period of visual development. Restor Neurol Neurosci (2010) 1.33
Quality control of individual components used in Middlebrook 7H10 medium for mycobacterial susceptibility testing. J Clin Microbiol (1988) 1.32
Use of immunofluorescence and animal tests to detect growth and toxin production by Clostridum botulinum type E in food. Appl Microbiol (1968) 1.32
Yeast glycolytic mRNAs are differentially regulated. Mol Cell Biol (1991) 1.32
Clostridium botulinum type F: isolation from venison jerky. Appl Microbiol (1972) 1.31
Review of AIDS and HIV infection: global epidemiology and statistics. AIDS (1989) 1.30
Specificity of a monoclonal antibody for the NH2-terminal region of fibrin. Mol Immunol (1984) 1.29
Chronic stressors and maternal depression: implications for prevention. Am J Public Health (1989) 1.28
IL-1 beta-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor. J Immunol (1994) 1.28
The InSiGHT database: utilizing 100 years of insights into Lynch syndrome. Fam Cancer (2013) 1.27
Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). Am J Cardiol (1994) 1.27
Use of immunofluorescence to identify Clostridium botulinum types A, B, and E. Public Health Rep (1967) 1.26
Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant (2012) 1.24